This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Raw JSON (canonical form + also see JSON Format Specification)
Intravenous Chemotherapy (Inpatient order) - Brentuximab Vedotin
{ "resourceType": "MedicationAdministration", "id": "medadmin0305", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: medadmin0305</p><p><b>instantiatesUri</b>: <a>http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a></p><p><b>status</b>: completed</p><p><b>medication</b>: </p><p><b>subject</b>: <a>Donald Duck. Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male; </a></p><p><b>encounter</b>: <a>encounter who leads to this prescription. Generated Summary: id: f001; id: v1451 (OFFICIAL); status: completed; <span>ambulatory</span>; <span>Patient-initiated encounter</span>; <span>Non-urgent cardiological admission</span>; 140 min; <span>Heart valve replacement</span></a></p><p><b>occurence</b>: 15/01/2015 2:30:00 PM --> 16/01/2015 12:30:00 AM</p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Patrick Pump. Generated Summary: id: f007; id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); ph: 020556936(WORK), S.M.Heps@bmc.nl(WORK), fax: 0205669283(WORK); gender: female; birthDate: 1971-11-07</a></td></tr></table><p><b>request</b>: <a>Generated Summary: id: medrx0316; id: 12345689 (OFFICIAL); status: completed; intent: order; <span>#med0306</span>; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf; </a></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td><td><b>Rate[x]</b></td></tr><tr><td>*</td><td>1.8 mg/kg IV infusion over 30 minutes</td><td><span>Intravenous</span></td><td>1.8 mg/kg</td><td>20 min</td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0306", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "51144-050-01", "display": "Adcetris" } ] }, "manufacturer": { "reference": "Organization/mmanu" }, "doseForm": { "coding": [ { "system": "http://snomed.info/sct", "code": "421637006", "display": "Lyophilized powder for injectable solution (qualifier value) " } ] }, "batch": { "lotNumber": "12345", "expirationDate": "2019-10-31" } } ], "instantiatesUri": [ "http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf" ], "status": "completed", "medication": { "reference": { "reference": "#med0306" } }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "encounter": { "reference": "Encounter/f001", "display": "encounter who leads to this prescription" }, "occurencePeriod": { "start": "2015-01-15T04:30:00+01:00", "end": "2015-01-15T14:30:00+01:00" }, "performer": [ { "actor": { "reference": "Practitioner/f007", "display": "Patrick Pump" } } ], "request": { "reference": "MedicationRequest/medrx0316" }, "dosage": { "text": "1.8 mg/kg IV infusion over 30 minutes", "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "255560000", "display": "Intravenous" } ] }, "dose": { "value": 1.8, "unit": "mg/kg", "system": "http://unitsofmeasure.org", "code": "mg/kg" }, "rateQuantity": { "value": 20, "unit": "min", "system": "http://unitsofmeasure.org", "code": "min" } } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.